Chlamydia trachomatis causes common infections of the eyes and genital tract in man. The mechanism by which this obligate intracellular bacterium is taken into epithelial cells is unclear. The results described here support the concept that chlamydial infection of HeLa cells is under bidirectional cyclic nucleotide control, with guanosine 3' :5'-cyclic monophosphate (cGMP) acting as a stimulator, and adenosine 3':5'-cyclic monophosphate (CAMP) as an inhibitor. Treatment of the HeLa cells with the divalent cation ionophore A23 187, with carbamoylcholine, or with prostaglandins known to increase the concentration of endogenous cGMP, also increased host cell susceptibility to chlamydial infection. Cyclic GMP was only effective if added at or before chlamydial inoculation, suggesting that its main effect was on chlamydial uptake. The stimulatory effect of cGMP, but not antagonism by CAMP, was abolished if the cells were first treated with any of four different inhibitors of prostaglandin synthesis, suggesting a critical role for endogenous prostaglandin synthesis. Centrifugation of chlamydiae on to host cells was followed by a rapid increase in the mobility of Ca2+ across the cell membrane. The interrelationships of these observations and the possibility that chlamydiae and other intracellular pathogens might evoke alterations in host cell prostaglandin and cyclic nucleotide concentrations to aid their own uptake are discussed.
I N T R O D U C T I O N
Chlamydiae are specialized bacteria which have adapted to obligate intracellular life in non-phagocytic cells by the development of a specialized growth cycle (Moulder, 1974) . The rigid 0.3 pm diameter elementary body enters the host cell and enlarges within a cytoplasmic vacuole to form the reticulate body: the latter divides by binary fission producing the characteristic inclusion. Elementary bodies differentiate from the reticulate bodies; their release some 48-72 h after infection completes the growth cycle. Relatively little is known concerning the mechanism by which intracellular pathogens enter non-phagocytic host cells. In the case of chlamydiae special mechanisms must exist as they are taken up by HeLa or L cells 10-100 times faster than polystyrene latex particles or Escherichia coli (Byrne & Moulder, 1978) . Chlamydia1 uptake requires energy from glycolysis (Kuo & Grayston, 1976) and electron microscope studies suggest that chlamydiae enter host cells by phagocytosis (Stirling & Richmond, 1977) . Thus both the parasite and the host cell participate in chlamydial uptake and the stimulus for uptake must be generated at the host cell surface.
The cyclic nucleotides adenosine 3':5'-cyclic monophosphate (CAMP) and guanosine 3' :5'-cyclic monophosphate (cGMP) are ubiquitous in eukaryotic cells. The intracellular concentrations of these nucleotides can be modulated by appropriate stimuli at the cell surface and control many critical cell functions, including phagocytosis and lysosomal degranulation ( 
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laboratory suggested that the susceptibility of HeLa 229 cells to infection with C. trachomatis was under bidirectional cyclic nucleotide control, with cGMP stimulating and CAMP depressing chlamydial infectivity (Ward & Salari, 1980) . The present paper confirms these observations and describes experiments suggesting that host cell prostaglandin biosynthesis and the concentration of intracellular calcium are also important in determining HeLa cell susceptibility to chlamydial infection.
M E T H O D S
Materials. Chlamydia trachomatis strains A/SA-1/OT, E/DK-20/0N, H/UW-4/GCx and L3/404/LN were kindly provided by Drs S . Darougar and J. Treharne, Institute of Ophthalmology, London, U.K. After receipt, the strains were passaged once in hens' egg yolk sacs and frozen at -70 OC. Reagents were obtained from the following sources: ZP,O2'-dibutyryl adenosine 3'5'-cyclic monophosphate (dibutyryl CAMP), P,O*'-dibutyryl guanosine 3'5'-cyclic monophosphate (dibutyryl cGMP), acetylsalicylic acid, l-(p-chlorobenzoyl)-5-methoxy-2-methylindol-3-ylacetic acid (indomethacin), carbamoylcholine chloride and emetine hydrochloride from Sigma; purified N-2,3-xylylanthranilic acid (mefenamic acid) from Parke Davis Co., Pontypool, Gwent, U.K.; 2-(2-fluoro-4-biphenylyl)propionic acid (Froben) from Boots Ltd, Nottingham, U.K. Ionophore A23 187 was a generous gift from Dr R. Hamill, Lilly Research Laboratories, Indianapolis. Ind. 46206, U.S.A., and prostaglandins El, E, and FZu promethamine salt were kindly donated by Upjohn Limited, Crawley, Sussex, U.K. 3H-labelled amino acid mixture TRK .440 and 45CaC1, CES. 3 were purchased from Amersham, and Hoechst 33258 from Hoechst (U.K.), Hounslow, Middlesex, U.K. Stock solutions of reagents were dissolved in MEM (see next section), with the exception of A23 187 which was dissolved in ethanol.
Tissue culture. HeLa 229 cells (Flow Laboratories, Irvine, U.K.) were grown at 35.5 O C in an atmosphere of 5 % (v/v) CO, in air in Eagle's Minimal Essential Medium supplemented with 10% (v/v) foetal calf serum, non-essential amino acids, L-glutamine and sodium bicarbonate (MEM). The absence of mycoplasma contamination from the cell cultures was confirmed weekly by fluorescence microscope examination of fluorochrome-stained (Hoechst 33258) preparations of the cells (Russell et al., 1975) .
Chlamydia1 amino acid utilization. The effect of cyclic nucleotides and other host-cell perturbing agents on the ability of the cells to support chlamydial growth was assessed by measuring the chlamydia-dependent utilization of radioactive amino acids. HeLa 229 cells were grown overnight to confluent monolayers in 1.5 ml volumes of MEM in 24-well tissue culture trays (Costar, Cambridge, Mass. 02139, U.S.A.). Each well contained approximately 5 x lo5 cells. After washing in Hanks' balanced salt solution (HBSS) the monolayers were incubated for 2 h at 35.5 OC in MEM containing 1 pg emetine hydrochloride ml-' with or without (control) the agent under test. Emetine hydrochloride blocks host cell (80s ribosome-dependent) protein synthesis without impairing the 70s ribosome-dependent protein synthesis of chlamydiae (Becker & Asher, 1972; Salari & Ward, 1981) . After a further wash in HBSS, 500 pl volumes of either MEM (uninfected control) or of a dilution of yolk sac-derived chlamydiae in MEM, with or without the test agent, were inoculated into each well as appropriate. The chlamydial inoculum was standardized so that inclusions developed in approximately 30 % of the control, emetine-treated, HeLa cells. The trays were centrifuged for 1 h at 2000 g then incubated for a further 2 h at 35.5 "C in 5 % (v/v) CO, in air to permit chlamydial adsorption. After washing in HBSS to remove unadsorbed chlamydiae, 1.5 ml MEM containing 1-5 pg emetine hydrochloride plus 1.5 pCi tritiated amino acids with or without test agent was added to each well and the trays were incubated at 35.5 "C. Uptake of radioactive amino acids into the infected cells was determined by first washing the cells thoroughly in HBSS at room temperature then solubilizing the cells in 1 ml 1 % (w/v) sodium dodecyl sulphate (SDS) at 35.5 OC overnight. The radioactivity in 800 pl samples of the resulting solution was quantified by liquid scintillation counting. The controls routinely included were uninfected cells plus and minus emetine to ensure that the host cell protein synthesis was blocked, and emetine-treated uninfected cells plus the test agent to ensure that the agent was not cytotoxic. Cytotoxicity was also monitored by direct microscope counting of the number of HeLA cells adherent to the cover slips after incubation with the test agent and prior to digestion in SDS. Preliminary experiments established that the bulk (> 90 %) of radioactivity taken up by emetine-treated, chlamydia-infected cells was incorporated into protein and could be recovered by precipitation with 5 % (w/v) trichloroacetic acid. This incorporation was due to chlamydial protein synthesis as it was almost entirely prevented by the addition of the antichlamydial agent rifampicin at 1 pg ml-'. Comparison of the chlamydia-dependent radioactive amino acid incorporation in 10 replicate wells showed the incorporation to be highly reproducible with a range of counts within k 4 % of the mean of 164 10 c.p.m. Points plotting cumulative chlamydial amino acid incorporation versus time bore a simple linear relationship to each other (e.g. Fig. 3 ) up to peak incorporation. It was, therefore, considered unnecessary to use replicate wells for each sample in experiments plotting cumulative amino acid incorporation versus time. In experiments in which amino acid incorporation at a fixed period of time was measured, the c.p.m. value plotted is Cyclic nucleotides, prostaglandins and chlamydiae 64 1 the mean of three replicate wells. Minor variations in the magnitude of individual responses (e.g. to cGMP) were observed from experiment to experiment, for unknown reasons, but the trends were always consistent. Each experiment was repeated at least once to establish its reproducibility. Inclusion counting. The effect of dibutyryl cAMP and dibutyryl cGMP treatment of HeLa cells on the number of inclusions developing from the standard inoculum of C. trachomatis was determined by direct counting of fluorochrome-stained inclusions. Confluent monolayers of HeLa 229 cells grown on 13 mm diameter coverslips in disposable 'bijou' bottles were treated for 2 h at 35.5 OC with various concentrations of dibutyryl cAMP and dibutyryl cGMP in the ranges of 10-3-10-6 M and 10-4-10--" M, respectively, in MEM in the absence of emetine. The monolayers were then inoculated with chlamydiae and incubated for 60 h at 35.5 "C to permit inclusion development. The coverslips were fixed in methanol, and the inclusions were stained with Hoechst 33258 (Salari & Ward, 1979) , then counted at a magnification of 625 x using a Leitz Ortholux I1 incident-light fluorescence microscope fitted with an ocular counting graticule. Quadruplicate coverslips were prepared for each variable and coded and the number of infected and uninfected cells in 32 randomly selected microscope fields was counted. The total number of cells per microscope field was approximately 90.
R E S U L T S

EfSect of treatment with different Concentrations of c_vclic nucleotides on HeLa cell
susceptibility to chlamydial infection. HeLa 229 cells were treated for 2 h before chlamydial inoculation and during subsequent incubation with different concentrations of dibutyryl cAMP or dibutyryl cGMP. [Dibutyryl analogues were used because they resist degradation by cellular phosphodiesterases and can penetrate intact HeLa cells (Kankel & Hilz, 1972) .] The effects of these treatments on the number of chlamydial inclusions developing from a standard inoculum of C. trachomatis UW4 are shown in Fig. 1 . In the absence of cyclic nucleotide treatment (control) a mean of 28 inclusions was observed per microscope field. Treatment with M dibutyryl cAMP reduced the number of inclusions developing by approximately two-thirds; this effect was dependent on concentration and at concentrations L 5 x lop4 M the number of inclusions was not significantly different from the controls. Treatment with dibutyryl cGMP at 10-4-10-5 M did not markedly affect the number of inclusions, but at concentrations in the range 10-6-10-8 M the number of inclusions was almost tripled. The cyclic nucleotides had no effect on the appearance of uninfected HeLa cell monolayers observed by phase-contrast microscopy.
These findings were confirmed using chlamydia-dependent uptake of radioactive amino acids as the parameter of growth (Fig. 2) . At high concentrations dibutyryl cAMP decreased the susceptibility of HeLa 229 cells to chlamydial infection, whereas dibutyryl cGMP increased their susceptibility at concentrations in the range 10-6-10-*' M but not at higher, non-physiological concentrations.
Action of cyclic nucleotides on the susceptibility of HeLa cells to infection with different serotypes of C. trachomatis. Different serotypes of C . trachomatis differ markedly in the type of disease they produce. Therefore the effect of treatment with optimal concentrations of dibutyryl cAMP and dibutyryl cGMP on the susceptibility of HeLa cells to other strains of C. trachomatis was determined.
Strains SAl (serotype A, trachoma isolate) and DK20 (serotype E, ophthalmia neonatorum) like UW4 (serotype H, genital tract infection) require centrifuge-assisted infection in tissue culture systems and have a 'slow' developmental cycle. By contrast, C. trachomatis 404 (serotype L3, lymphogranuloma venereum) produces a more invasive genital tract infection in man, has a 'fast' developmental cycle and infects HeLa or McCoy cells without the need for centrifugation. Despite these differences in the serotype and in the infections produced, growth of all the strains was enhanced by M-dibutyryl cGMP and suppressed by EfSect of compounds perturbing host cell cyclic nucleotide synthesis on chlamydiadependent uptake of radio-labelled amino acids. A variety of compounds, including prostaglandins and carbamoylcholine, are known to affect the concentrations of intracellular M-dibutyryl cAMP (Table 1) . cAMP or cGMP in a wide range of eukaryotic cells. Therefore such compounds would be expected to influence HeLa cell susceptibility to chlamydial infection. Figure 3 shows the effect on chlamydial amino acid uptake of treating HeLa 229 cells for 2 h before chlamydial challenge with dibutyryl cAMP ( M), prostaglandins E,, E, and FZa (2 x M) or carbamoylcholine (
M).
Emetine-treated uninfected HeLa cells (controls) showed an insignificant amount of amino acid incorporation, which was not affected by any of the agents under test. A slight, but consistent, loss of incorporated radioactivity in these metabolically inhibited cells was due to gradual death and exfoliation from the monolayer. Maximal chlamydia1 amino acid incorporation was noted at 54 h post-inoculation. Beyond this time, loss of radiolabelled cells from the monolayer due to the combined effects of metabolic inhibition and chlamydiadependent host cell lysis exceeded the cumulative incorporation of isotope resulting from continuing chlamydial development. Treatment with dibutyryl cGMP, carbamoylcholine and prostaglandins E, and Fan caused a consistent increase in chlamydia-dependent amino acid uptake compared with control (untreated) cells. By contrast, dibutyryl cAMP and prostaglandin E, depressed chlamydial amino acid uptake. This opposed effect of the two E series prostaglandins was dependent on concentration; when retested at the lower, more physiological concentration of 5 x M, prostaglandins E, and E, both consistently depressed the susceptibility of the HeLa cells to chlamydial infection ( Table 2) .
Action of cyclic nucleotides at different stages of the chlamydial growth cycle.
Cyclic nucleotides might act early in the chlamydial growth cycle to affect the uptake and survival of the elementary bodies, or they might act later in the development cycle, perhaps influencing the differentiation of reticulate bodies to elementary bodies. To discriminate between these possibilities, the effect of adding dibutyryl cGMP (lop6 M) at different stages in the chlamydial growth cycle was examined. Addition of dibutyryl cGMP 2 h before challenge with C. trachomatis UW4 almost doubled chlamydia-dependent amino acid uptake when compared with the infected, untreated control cells (Fig. 4) . Addition of dibutyryl cGMP with the challenge inoculum or 3-30 h after challenge had no significant effect. To ensure that this observation was representative of all C. trachomatis strains the experiment was repeated with further strains, the effect on chlamydial growth being assessed by inclusion counting. Results for strains DK-20 (Ward & Salari, 1980 ) SAl and LGV404 (data not shown) again confirmed that both cAMP and cGMP were maximally effective when added 2 h before chlamydial challenge and had little effect if added 3 h after inoculation.
Role of endogenous prostaglandin. The possibility that endogenous prostaglandin synthesis might be important in the action of cyclic nucleotides on chlamydial growth was investigated. HeLa cells were grown overnight in the presence of the prostaglandin biosynthesis inhibitors acetylsalicyclic acid ( lop4 M), Froben, mefenaqate or indomethacin (2 x lop5 M) in order to deplete the cells of endogenous prostagla9n and block de novo synthesis. The susceptibility The following day the medium was replaced with MEM containing cyclic nucleotide and/or prostaglandin synthesis inhibitor (Pg inhibitor) as appropriate. After 1 h the cells were challenged with C. trachomatis UW4 and then incubated with the appropriate cyclic nucleotide and/or inhibitor in medium containing 1 pg emetine ml-' and 1 pCi )H-labelled amino acids ml-'. Cumulative chlamydia-dependent amino acid incorporation was determined 48 h after inoculation. As controls (numbered columns), amino acid incorporation by emetine-treated cells was also determined for uninfected cells in the absence (1) or presence (2) of test agent, for untreated infected cells (3), and for infected cells treated with either dibutyryl cAMP (4) or dibutyryl cGMP (5).
M-acetylsalicylic acid (A),
of normal and prostaglandin-depleted cells to infection with C. trachomatis UW4 after treatment with either dibutyryl cAMP or cGMP was compared using chlamydia-dependent radio-labelled amino acid incorporation (Fig. 5) .
Treatment of HeLa cells with each of the four inhibitors of prostaglandin synthesis slightly but consistently depressed chlamydia-dependent amino acid incorporation. In both normal and prostaglandin-inhibited HeLa cells treatment with dibutyryl cAMP caused a comparable decrease in susceptibility to chlamydial infection. The increased susceptibility of normal HeLa cells to chlamydial infection resulting from dibutyryl cGMP treatment was blocked in cells treated with any of the four prostaglandin synthesis inhibitors. Thus, the stimulatory effect of dibutyryl cGMP on chlamydial growth in HeLa cells, but not the inhibitory action of dibutyryl CAMP, is evidently mediated via the biosynthesis of prostaglandins or related compounds.
Action of intracellular calcium. The roles of intracellular calcium and of cyclic nucleotides are often interrelated. The effect on chlamydial development of treating HeLa cells with A23 187, an ionophore which selectively elevates intracellular Ca2+ content, was investigated.
HeLa 229 cells were treated before chlamydial inoculation with cyclic nucleotide or with ionophore (Fig. 6) . In some cases, cyclic nucleotide-treated cells were exposed to the ionophore before challenge. The effects of these treatments on chlamydial development were determined by measuring the chlamydia-dependent incorporation of radio-labelled amino acids. The results show that dibutyryl cGMP or A23 187 treatment of HeLa cells increased their susceptibility to infection with C. trachomatis whereas dibutyryl cAMP treatment decreased it. This inhibitory effect of dibutyryl cAMP was abolished if the cells were subsequently treated with ionophore before chlamydial challenge. Thus A23 187 treatment or M-dibutyryl cGMP ( 0 ) for 2 h, with 1 pg A23 187 ml-(A) for 1 h; or with dibutyryl cAMP (2 h) followed by A23187 for 1 h (A), in MEM. Control infected (0) or uninfected (0) cells remained untreated. After washing, the cells were challenged and incubated in MEM containing 1 pg emetine ml-I, 1 pCi 3H-labelled amino acids ml-' and, as appropriate, cyclic nucleotides. Cumulative amino acid incorporation due to chlamydial growth was then determined. stimulated chlamydial infection, showing it had no significant toxic effect on the host cells (since chlamydial growth requires active host cell metabolism), and modified the interactions of the host cells with cyclic nucleotides.
Effect of chlamydial interaction with the HeLa cell surface on host cell calcium mobility.
The experiment with A23 187 suggested that if chlamydiae at the cell surface were capable of increasing calcium mobility in the host cell then they might trigger changes in the cell favourable to their own internalization. To investigate this possibility, the effect of chlamydiae on the influx and ef'Rux of 45Ca2f in the host cell was determined.
To determine calcium influx, a purified tissue-culture derived inoculum of C. trachomatis UW4 (Salari & Ward, 1981) in MEM was centrifuged at 0 "C on to a monolayer of HeLa 229 cells in order to deposit chlamydiae on the host cell surface. At this temperature the rate of enzyme-dependent reactions is low and membrane mobility greatly reduced. Thus it was considered unlikely that at 0 "C any chlamydia-induced changes in cell physiology could occur. Following centrifugation, the medium on the cells was replaced at 0 "C with a special medium, consisting of Hanks' balanced salts solution deficient in non-radioactive calcium, but containing 5 mM-Mg2+ and 2 pCi 45Ca2+ ml-' (modified HBSS). The cells were then rapidly warmed to 35.5 "C to restore enzyme activity and membrane mobility. At this stage, chlamydial adhesion to the membrane can be strengthened due to membrane fluidity increasing the area in contact with the chlamydial particle, and uptake begins. Radioactivity due to the associated influx of 45Ca2+ into chlamydial-inoculated or control (uninfected) cells was determined over a range of incubation times by washing the cell monolayer free of extracellular 45Ca2+, followed by solubilization in 1 % (w/v) SDS and scintillation counting. The results (Fig. 7) showed that chlamydial interaction with the host cell surface caused a rapid and marked increase in the uptake of calcium which was not observed in the uninfected controls. To distinguish whether this apparent uptake was due to increased calcium mobilization or to increased calcium binding sites at the host cell surface it was necessary to determine if there was a corresponding increased calcium efflux. To determine efflux, confluent monolayers of HeLa 229 cells were labelled with 45Ca2+ for 4 h at 35.5 OC in modified HBSS containing 2 pCi 45Ca2+ m1-I. The radio-labelled cells were thoroughly washed with ice-cold phosphate-buffered saline to remove unincorporated 45C a2+, then inoculated by centrifugation at 0 " C with the purified tissue-culture derived inoculum of C. trachomatis UW4. After inoculation, the medium on the cells was replaced with normal HBSS at 0 OC, the cells were rapidly warmed to 35.5 " C , and the efflux of 45Ca2+ from the labelled cells into the supernatant medium was determined at various time intervals. The results (Fig. 8) showed that chlamydia1 interaction markedly enhanced the efflux of calcium over that noted in uninfected (control) cells. Thus interaction between purified chlamydial elementary bodies and the host cell surface resulted in an increased mobilization of calcium which was reflected by an increase in both the influx and efflux of the cation.
D I S C U S S I O N
It is now generally accepted that the cyclic nucleotides cAMP and cGMP, together with calcium, are major components of an internal signalling system regulating eukaryotic cell activities. Two types of cyclic nucleotide-based control systems have been identified (Goldberg et al., 1974) . In the monodirectional system either cAMP or cGMP mediates an effect in cooperation with calcium. In the bidirectional system the effect of cGMP or calcium antagonizes the effect of CAMP. The results described in this paper showed that exogenous dibutyryl cGMP or compounds, such as carbamoylcholine and prostaglandin Fla, known to increase endogenous eukaryotic cell cGMP levels, increased the susceptibility of HeLa cells , 1972) , also stimulated infection. By contrast, dibutyryl CAMP, or prostaglandin E, which stimulates endogenous eukaryotic cell cAMP synthesis (Samuelsson et al., 1978) , depressed the chlamydial infection. This effect of cAMP was abolished if the cyclic nucleotide-treated cells were treated with A23 187 before chlamydial challenge. These findings, together with the fact that dibutyryl cGMP was only active at much lower concentrations ( 10-6-10-11 M) than dibutyryl cAMP ( 10-3-10-4 M) were consistent with the operation of a bidirectional control system (Goldberg & Haddox, 1977) in which cGMP or intracellular Ca2+ functions as agonist and cAMP as antagonist. The only apparently disparate finding in this respect was the opposed action of prostaglandins El and E, at 2 x lops M; in general prostaglandins of the E series act as cAMP inducers (Samuelsson et al., 1978) . However, as observed in other systems this opposed effect was dependent on the prostaglandin concentration (Salzman, 1972) ; when retested at the more physiological concentration of 5 x lo-' M, prostaglandins E, and E, both depressed the susceptibility of HeLa cells to chlamydial infection as would be expected of cAMP inducers.
The fact that cGMP was only effective when added before chlamydial inoculation (Fig. 4) shows that the nucleotide must affect an early stage in the process of infection e.g. chlamydial attachment or uptake. Chlamydia trachomatis UW4 in either the presence or absence of cGMP fails to grow in HeLa cells unless centrifuged on to the host cell surface, suggesting that it is defective in its ability to attach to this cell line irrespective of the presence of cGMP. Analysis of the binding of polyvalent ligands to cell membranes suggests that invagination of the host cell membrane following virus or chlamydial attachment may be the most thermodynamically stable configuration for the membrane to adopt (Patterson et al., 1979 ). Uptake will be achieved either by fusion of the opposed plasma membrane of the invagination to form an intracellular vacuole or by sequential binding of the host cell membrane to the chlamydial surface resulting in uptake by a 'zipper mechanism' similar to that described by Griffin et al. (1975) . In the case of the chlamydiae, close adhesion to the membrane and uptake are apparently part of the same process and cannot readily be distinguished. The finding that cGMP was relatively ineffective when added at chlamydial challenge, rather than 2 h before, suggests time is required to bring about an appropriate metabolic change. This change occurred irrespective of the presence of the protein synthesis inhibitor emetine. One possibility is that cGMP increases host cell membrane fluidity, mobility or ability to fuse, so favouring uptake.
Two different experiments point to a major role for prostaglandins in determining the susceptibility of HeLa cells to chlamydial infection. Firstly, addition of exogenous prostaglandins directly influenced chlamydial infectivity. Secondly, the stimulatory effect of cGMP was blocked by prior treatment of the cells with any of the four, structurally unrelated, inhibitors of prostaglandin biosynthesis tested. The stimulatory effect of A23 187 treatment on chlamydial infection might also have been due to stimulation of prostaglandin biosynthesis, perhaps by calcium-dependent stimulation of phospholipase A, in the host cell membrane. Certainly, in macrophages, A23 187 treatment leads to a burst of prostaglandin biosynthesis (Gemsa et al., 1979) . In this context the inhibitory action of cAMP on HeLa susceptibility to chlamydial infection might be explained by its ability to inhibit pr&taglandin biosynthesis, either by blocking the release of precursor fatty acids from membrane lipids by phospholipase A, (Minkes et al., 1977) or by inhibiting the formation of prostaglandin endoperoxides (Malmsten et al., 1976) . This would explain why the inhibitory action of cAMP on chlamydial infection was unaffected by prior treatment of the HeLa cells with prostaglandin biosynthesis inhibitors.
The results presented show that alterations in the concentrations of cyclic nucleotides and prostaglandins are capable of interacting to affect the susceptibility of HeLa cells to chlamydial infection. Further understanding of the mechanism involved and of the role of prostaglandin synthesis will necessitate direct assay of individual prostaglandin and cyclic
